US Broker Ratings

Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 49% Potential Upside

Clover Health Investments, Corp (NASDAQ: CLOV) presents an intriguing opportunity for investors looking into the healthcare sector, with a significant potential upside of 49.17%. As a player in the healthcare..

Mesoblast Limited (MESO) Stock Analysis: Unveiling a Potential 126.83% Upside

Investors eyeing opportunities within the biotechnology sector might find Mesoblast Limited (NASDAQ: MESO) particularly intriguing. This Australian healthcare entity, with a market capitalization of $2.05 billion, is making waves due..

NovoCure Limited (NVCR) Stock Analysis: Can its Tumor Treating Innovations Drive a 100% Upside?

NovoCure Limited (NASDAQ: NVCR), a pioneering healthcare company in the medical devices sector, has captured significant investor attention with its innovative approach to cancer treatment. Specializing in tumor treating fields..

Ascentage Pharma (AAPG) Stock Analysis: Uncovering a 108% Upside Potential in Biotech Innovations

Ascentage Pharma Group International (NASDAQ: AAPG), a pioneering force in the biotechnology sector, is gaining traction with investors due to its robust pipeline of innovative therapies targeting cancer, chronic hepatitis..

Kymera Therapeutics (KYMR) Stock Analysis: Exploring a 40.77% Potential Upside in the Biotech Sector

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a pioneering force in the biotechnology sector, has captured the attention of investors with its innovative approach to drug development. As a clinical-stage biopharmaceutical company,..

Phreesia, Inc. (PHR) Stock Analysis: Is the 132% Potential Upside Worth the Investment?

Phreesia, Inc. (PHR) is carving a niche within the healthcare sector as a provider of integrated SaaS-based software and payment platforms. Operating primarily in the United States and Canada, Phreesia..

Immunocore Holdings (IMCR) Stock Analysis: Exploring a 94.59% Potential Upside in the Biotech Arena

Investors with a keen eye on the biotechnology sector should not overlook Immunocore Holdings plc (NASDAQ: IMCR), a promising player in the healthcare industry with a current market cap of..

LifeStance Health Group, Inc. (LFST) Investor Outlook: Exploring a 42% Potential Upside in Mental Health Services

LifeStance Health Group, Inc. (LFST), a prominent player in the healthcare sector, operates within the medical care facilities industry, focusing on mental health services across the United States. With a..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A 41% Potential Upside in the Biotech Sector

Apogee Therapeutics, Inc. (NASDAQ: APGE) is making waves in the biotechnology sector with its promising pipeline of novel biologics aimed at treating a range of inflammatory and immunology conditions. With..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring a 68% Potential Upside in the Healthcare Sector

AtriCure, Inc. (NASDAQ: ATRC), a notable player in the healthcare sector, stands out as an intriguing opportunity for investors with its robust product portfolio and promising growth prospects. With a..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Investors Eye Nearly 89% Potential Upside with Strong Buy Ratings

Alphatec Holdings, Inc. (ATEC), a key player in the medical devices sector, is capturing investor attention with its innovative approach to spinal disorder treatments and a notable potential upside of..

Centessa Pharmaceuticals (CNTA): Exploring a 51.95% Potential Upside in the Biotech Sector

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is making waves in the biotechnology industry with its innovative approach to drug development. Headquartered in Altrincham, United Kingdom, Centessa is a clinical-stage pharmaceutical company..

Travere Therapeutics, Inc. (TVTX) Investor Outlook: A 47% Potential Upside Beckons

For investors with a penchant for the healthcare sector, particularly in the biotechnology industry, Travere Therapeutics, Inc. (TVTX) presents an intriguing opportunity. As a biopharmaceutical company focused on rare kidney..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: A 16.61% Potential Upside Awaits Investors

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a key player in the healthcare sector specializing in the development and commercialization of treatments for central nervous system (CNS) diseases, is drawing investor attention..

Haemonetics Corporation (HAE) Stock Analysis: Unpacking the 37% Potential Upside

Haemonetics Corporation (NYSE: HAE), a stalwart in the healthcare sector, specifically within the medical devices industry, is drawing investor attention with its compelling growth potential. With a current market capitalization..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Navigating the Biotech Terrain with a 54.52% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI), a prominent player in the biotechnology sector, is making waves with its innovative approach to treating neurodegenerative and lysosomal storage diseases. With a market capitalization..

Schrodinger, Inc. (SDGR) Investor Outlook: Exploring an 81% Potential Upside Amidst Healthcare Innovations

Schrodinger, Inc. (NASDAQ: SDGR) presents a compelling opportunity for investors seeking exposure to the healthcare sector, particularly within the realm of health information services. Headquartered in New York, Schrodinger leverages..

Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Assessing a 41.72% Potential Upside

As the medical devices sector continues to innovate, Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands out with its focus on improving the lives of diabetes patients through state-of-the-art technology. Headquartered..

Addus HomeCare Corporation (ADUS): Investor Outlook with a 36% Potential Upside

Addus HomeCare Corporation (NASDAQ: ADUS) stands out as a compelling player in the healthcare sector, specifically within the Medical Care Facilities industry. With a market capitalization of $1.9 billion, Addus..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring Growth Potential Amidst a 16.9% Revenue Surge

Twist Bioscience Corporation (NASDAQ: TWST), a pioneer in synthetic DNA production, remains a compelling investment opportunity in the healthcare sector, particularly within diagnostics and research. Headquartered in South San Francisco,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds